Jerry Call

/Jerry Call

About Jerry Call

This author has not yet filled in any details.
So far Jerry Call has created 72 blog entries.

New Technology Developed Which Can Predict GIST Patient’s Response to Drugs with Amazing Accuracy

Researchers have developed a test that can accurately identify over 20% of GIST patients that are unlikely to respond to currently approved treatments. In addition, it can identify which patients need a higher dose [...]

By |2019-07-03T10:48:28-04:00June 29th, 2018|GIST Education, Mutational Testing, News, Newsletter|

Deciphera Pharmaceuticals Announces the Start of Phase 3 Clinical Trial with DCC-2618 in GIST

On January 4th, 2018 Deciphera Pharmaceuticals, Inc, announced the start of the Phase 3 INVICTUS trial. This randomized trial is for 4th line GIST patients that have failed (or are intolerant) the [...]

By |2018-10-29T13:46:27-04:00January 9th, 2018|Clinical Trials, News|

Clinical Registry Study Planned by ASCO

American Society of Clinical Oncology (ASCO) is planning its first-ever clinical registry study, the Targeted Agent and Profiling Utilization Registry (TAPUR).  ASCO plans should increase patient access to off-label drugs and match patients with [...]

By |2018-07-06T13:59:34-04:00January 6th, 2015|Gleevec, News, Patient Support, Side Effects, Stivarga, Sutent|

Recent Posts

Upcoming Events

  1. GIST Awareness Day

    GIST Awareness Day – Nairobi, Kenya

    July 20 @ 8:00 AM - 11:00 AM
  2. SPAEN hosts webcast by Dr. Trent

    Novel Treatments in GIST

    July 24 @ 2:00 PM
  3. LRG Webcast Series: When to Consider Surgery

    August 8 @ 2:00 PM - 3:00 PM